News
Pfizer Expands Approval for Braftovi and Mektovi Combination in Metastatic Non-Small Cell Lung Cancer
Pfizer, a renowned New York drugmaker, has recently achieved expanded approval from the U.S. Food and Drug Administration (FDA) for its powerful combination ...